Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H15NO2 |
Molecular Weight | 241.2851 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(NCCC2=CC=CC=C2)C=CC=C1
InChI
InChIKey=HLNLBEFKHHCAMV-UHFFFAOYSA-N
InChI=1S/C15H15NO2/c17-15(18)13-8-4-5-9-14(13)16-11-10-12-6-2-1-3-7-12/h1-9,16H,10-11H2,(H,17,18)
Enfenamic acid (under brand name tromaril) is an anthranilic acid derivative with potent anti-inflammatory, anti-arthritic, analgesic and antipyretic actions. It has additional unique property of anti-platelet aggregation activity, without disturbing any other blood coagulation factors. It also differs from other non-steroidal anti-inflammatory agents like indomethacin, in producing diuresis and natriuresis. In the clinical study, tromaril showed itself as a strong and effective drug for use in various eye diseases.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6367599
Unknown
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3004495
Incubation of liver cells in the presence of 1.0 mM enfenamic acid inhibited the output of glucose. And also the in vitro addition of various concentrations of enfenamic acid (0.25 to 3.0 mM) to the tissue extracts of liver inhibited the activities of important gluconeogenic enzymes such as pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK) and fructose 1,6-diphosphatase (FDPase). These findings indicated that the impairment of gluconeogenesis might be due to the inactivation of the enzymes by the drug.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
31635
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
DTXSID8057693
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
23049-93-6
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
m1133
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2106178
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
100000080229
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
SUB06529MIG
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
4973
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
C72088
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
C019126
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
05KO5G76R2
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
3176
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY